1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 1-o-hexadecyl-2-lyso-glycero-3-phosphorylcholine in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (1-o-hexadecyl-2-lyso-glycero-3-phosphorylcholine) | Trials (1-o-hexadecyl-2-lyso-glycero-3-phosphorylcholine) | Recent Studies (post-2010) (1-o-hexadecyl-2-lyso-glycero-3-phosphorylcholine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 7 | 0 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lucchesi, BR; Mickelson, JK; Simpson, PJ | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 1-o-hexadecyl-2-lyso-glycero-3-phosphorylcholine
| Article | Year |
|---|---|
Myocardial dysfunction and coronary vasoconstriction induced by platelet-activating factor in the post-infarcted rabbit isolated heart.
Topics: Animals; Coronary Vessels; Heart; Male; Myocardial Infarction; Myocardium; Perfusion; Platelet Activating Factor; Rabbits; Vasoconstriction; Vasoconstrictor Agents | 1988 |